1US FDA new drug expedited review strategies and its implications for ChinaYUAN Lin, SHAO Ming-li2401-2404,24092Thinking and strategy on standard management of traditional Chinese medicine extractsCONG Luo-luo, WU Bin, ZHANG Jian-wu, SHAO Ming-li2405-24093Suggestions for clinical trial registration and information sharing in ChinaZONG Xin, DONG Jiang-ping, TAO Xiu-mei2410-24134Impacts of pharmaceutical industry innovation on patent output: an analysis based on data of three five-year plans in East ChinaHUO Yan-fei, YI Ba-xian, WANG Guang-ping, SHI Sheng-yi, CHEN Ying, LI Chi-rong2414-2419,24335Pharmaceutical procurement mode in Germany: the primary role of community pharmacyDONG Guo-qing, GUAN Hai-jing, LI Qian, LIU Guo-en, SUN Li-hua2420-24246Status of quality specification of highly toxic medicinal materials and discussion on related issuesZHOU Yue-hua, XU Zeng-lai, LU Jin-cai2425-24337Comparison of guidelines for new drug safety pharmacology studies between China and European UnionCHEN Yu-cai, ZHANG Hui-fang, FANG Lian-hua, DU Guan-hua2434-24368Progress in epidemiology and treatment of benign prostatic hyperplasia and erectile dysfunctionZHOU Yan, CHENG Jing, WANG Jin, TIAN Yu-wei, QI Qu, LI Jia-kui, WU Yong-qian2437-2447,24669Progress in toxicokinetics research of traditional Chinese medicinesGAO Fang-yuan, YUAN Bo-jun, MA Xiu-juan, XIA Zhen-na, LU Guo-cai2448-2452,245810Research progress in in vitro models for assessing drug transport across blood-brain barrierZHANG Jun-ying, DIAO Jin-fu, L(U) Qing-lin, WU Chun-yong2453-245811Influence factors of the pulmonary drug delivery process of dry powder inhalersTIAN Pei, YANG Zhi-qiang, WANG Xing-lin, ZHAO Ya-hui2459-246612Application and research situation of direct powder tableting technology and excipientsLI Jin-zhi, FENG Jin-rui, HE Tian, LIN Xiao2467-2470,249813Advances in research on the relationship between Wnt/β-catenin signal pathway and systemic sclerosisBIAN Hua, HAN Li, YANG Lei2471-247514Safety and tolerability of combination of retagliptin and valsartan in healthy volunteersYONG Xiao-lan, LI Nan, FENG Shi-yin, WANG Lan-tian, KANG Hui2476-247915Safety and efficacy of low-dose ticagrelor in patients with unstable angina pectoris and non-revascularizationLI Kang-bo, XU Ying-jun, HAN Quan-le2480-248416Structure-activity relationship analysis of 12-1ipoxygenase inhibitors based on Topomer CoMFA and molecular dockingAN Chun-hong, SHU Mao, WEN Xiao-rong, ZAI Xiao-li2485-2488,250617Effect of Lagotis brevituba Maxim.extract in reducing uric acid level in hyperuricemia mice and it's mechanism2489-249318Effect of decoction of burdock root on erectile dysfunction in rat modelsYAO Jia, CHEN Kao-shan, YU Li-zhen, LI Li-hua2494-249819Synthesis of an anti-type 2 diabetes mellitus drug, sitagliptinWU Ting, LIU Yuan, DONG Hong-xin, XIA Chao, SHI Jin-cheng2499-2501,251020In vitro releasing behavior of methazolamide nanoparticle eye drop and its ocular hypotensive effect in rabbitsLI Guang-yuan, LOU Jian-shi, CHEN Bin, LI Nan, WANG Xiao-hui, LIU Pei-li, ZHU Jun-mei2502-2506 